Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$66.63 USD

66.63
12,908,298

-0.22 (-0.33%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $66.63 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (233 out of 250)

Industry: Retail - Pharmacies and Drug Stores

Better trading starts here.

Zacks News

Foot Locker (FL) Stock Up 8.7% on Q3 Earnings and Sales Beat

Foot Locker (FL) posts better-than-expected earnings for third-quarter fiscal 2022. FL's FLX membership program and omnichannel capabilities appear encouraging.

Company News for Nov 3, 2022

Companies In The News Are: CVS, HUM, ETR, NVO.

CVS Health (CVS) Q3 Earnings Surpass Estimates, View Up

Robust sales growth across all three operating segments drive CVS Health's (CVS) top line.

CVS Health (CVS) Beats Q3 Earnings and Revenue Estimates

CVS Health (CVS) delivered earnings and revenue surprises of 5.03% and 6.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Herbalife LTD. (HLF) Surpasses Q3 Earnings Estimates

Herbalife LTD. (HLF) delivered earnings and revenue surprises of 22.97% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Shaun Pruitt headshot

Should Investors Buy CVS Stock Before Q3 Earnings?

Trading 15% from its highs, CVS (CVS) is set to report Q3 earnings on Wednesday, November 2. Investors hope the company can capitalize on its ambition to sustain itself as an industry leader as the Retail-Pharmacies Drug Stores Industry is currently in the top 18% of over 250 Zacks Industries.

Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

CVS Health (CVS) Gains As Market Dips: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $92.73, marking a +0.55% move from the previous day.

CVS Health (CVS) to Report Q3 Earnings: What's in the Cards?

CVS Health's (CVS) digital capabilities are anticipated to have enhanced consumer engagement across all CVS Health businesses in Q3.

Zacks Industry Outlook Highlights CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's

CVS Health, Walgreens Boots Alliance, Rite Aid and Amazon's are part of Zacks Industry Outlook article.

Urmimala Biswas headshot

3 Retail Pharmacy and Drugstore Stocks to Watch Amid Industry Challenges

The Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain from the growing demand for digital healthcare support. However, reimbursement challenges are hurting overall industry health.

CVS Health (CVS) Stock Moves -0.73%: What You Should Know

In the latest trading session, CVS Health (CVS) closed at $90.99, marking a -0.73% move from the previous day.

CVS Health (CVS) Stock Moves -0.89%: What You Should Know

CVS Health (CVS) closed at $89.30 in the latest trading session, marking a -0.89% move from the prior day.

The Zacks Analyst Blog Highlights Chevron, Amgen, HSBC, CVS Health and S&P Global

Chevron, Amgen, HSBC, CVS Health and S&P Global are included in this Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Chevron, Amgen & HSBC

Today's Research Daily features new research reports on 12 major stocks, including Chevron Corporation (CVX), Amgen Inc. (AMGN) and HSBC Holdings plc (HSBC).

Shaun Pruitt headshot

Walgreens Earnings Preview: Can WBA Stock Rebound?

WBA's upcoming earnings release on Thursday, October 13 will be closely monitored as many businesses struggle amid rising inflation and tougher operating environments. Investors will want to see some upbeat guidance more than anything else.

Company News for Oct 10, 2022

Companies In The News Are: LEVI, AMD, DXCM, CANO, CVS.

Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Rite Aid (RAD) Q2 Loss Wider Than Expected, Revenues Beat

Rite Aid (RAD) posts lower Q2 revenues from the year-ago fiscal quarter's level due to sluggishness in both the Retail Pharmacy and Pharmacy Services segments.

CVS Health (CVS) Gains But Lags Market: What You Should Know

CVS Health (CVS) closed at $98.16 in the latest trading session, marking a +0.98% move from the prior day.

CVS Health (CVS) Dips More Than Broader Markets: What You Should Know

CVS Health (CVS) closed the most recent trading day at $97.21, moving -0.54% from the previous trading session.

CVS Health (CVS) Stock Moves -1.55%: What You Should Know

CVS Health (CVS) closed at $99.77 in the latest trading session, marking a -1.55% move from the prior day.

CVS Health (CVS) Gains As Market Dips: What You Should Know

CVS Health (CVS) closed the most recent trading day at $102.31, moving +1.25% from the previous trading session.

CVS Health (CVS) Progresses With Safe Medication Approach

A major feature of CVS Health's (CVS) time delay safe function is that it cannot be overridden and is designed to deter pharmacy robbers.